Clinical Trials
Program Contacts
Clinical Trials
Program Overview
The Clinical Trials Program has actively engaged in over 30 investigator initiated and pharmaceutical funded clinical trials phased 2-4. Participants for these trials are recruited to help investigate treatments that focus on a new drug, combination of drugs, or a new strategy for existing therapies. Through these trials, the program contributes invaluable information to the field of medical therapy, influencing research and understanding of new ways to better prevent, detect and understand diabetes around the globe.
For more information about the clinical trials program, please contact Marnie Orcutt.
Current Trials
Our Team is currently running three active studies at our fully-equipped research site, which include: COMBINE 2, Remit-IDegLira and PROMISE.
Currently Recruiting
Please check back regularly for updates.
